List of bibliographic references
Number of relevant bibliographic references: 69.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000168 (2013) |
Olivier Rascol | Physical exercise in Parkinson disease: Moving toward more robust evidence? |
| 000183 (2006) |
Olivier Rascol | Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: An important but still unmet need |
| 000193 (2004) |
Gilles Angibaud ; Claude Gaultier ; Olivier Rascol | Atypical parkinsonism and Annonaceae consumption in New Caledonia |
| 000219 (1995) |
Jean-Louis Montastruc ; Nelly Fabre ; Olivier Blin ; Jean-Michel Senard ; Olivier Rascol ; André Rascol | Does fluoxetine aggravate Parkinson's disease? A pilot prospective study |
| 000418 (2004) |
Olivier Rascol ; Atul Pathak ; Haleh Bagheri ; Jean-Louis Montastruc | Dopaminagonists and fibrotic valvular heart disease: Further considerations |
| 000471 (1999) |
Erwan Bezard ; Christine Brefel ; Francois Tison ; Helene Peyro-Saintpaul ; Philippe Ladure ; Olivier Rascol ; Christian E. Gross | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey |
| 000645 (1997) |
Nathalie Andreu ; Christine Damase-Michel ; Jean-Michel Senard ; Olivier Rascol ; Olivier Montastruc | A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity |
| 000792 (1992) |
Geneviève Durrieu ; Marie-Elise Llau ; Olivier Rascol ; Jean-Michel Senard ; André Rascol ; Jean-Louis Montastruc | Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment |
| 000808 (2001) |
Jean-Louis Montastruc ; Karine Desboeuf ; Maryse Lapeyre-Mestre ; Jean-Michel Senard ; Olivier Rascol ; Christine Brefel-Courbon | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 000840 (2007) |
Joaquim Ferreira ; João Maia Silva ; Rita Freire ; João Pignatelli ; Leonor Correia Guedes ; Alexandra Feij ; Mário Miguel Rosa ; Miguel Coelho ; João Costa ; Ana Noronha ; Russell Hewett ; A. Marques Gomes ; J. L. Cirne De Castro ; Olivier Rascol ; Cristina Sampaio | Skin cancers and precancerous lesions in Parkinson's disease patients |
| 000A66 (2010) |
Santiago Perez-Lloret ; Emmanuelle Bondon-Guitton ; Olivier Rascol ; Jean-Louis Montastruc | Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database |
| 000B80 (2012) |
Andrew Lees ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M. Maral Mouradian ; Wolfgang H. Oertel ; C. Warren Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease |
| 000D37 (1999) |
Jean-Louis Montastruc ; Marc Ziegler ; Olivier Rascol ; Muriel Malbezin | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 000D45 (2010) |
Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000E31 (2004) |
Jan C. M. Zijlmans ; Berengere Debilly ; Olivier Rascol ; Andrew J. Lees ; Franck Durif | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 000F67 (1999) |
Jean Louis Montastruc ; Olivier Rascol ; Jean-Michel Senard | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 001074 (2003) |
Olivier Rascol ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira ; Christine Brefel-Courbon ; Jean-Louis Montastruc | Limitations of current Parkinson's disease therapy |
| 001087 (2005) |
Christine Brefel-Courbon ; Pierre Payoux ; Claire Thalamas ; Fabienne Ory ; Isabelle Quelven ; François Chollet ; Jean Louis Montastruc ; Olivier Rascol | Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
| 001120 (2013) |
Anthony E. Lang ; Eldad Melamed ; Werner Poewe ; Olivier Rascol | Trial designs used to study neuroprotective therapy in Parkinson's disease |
| 001192 (2006) |
Olivier Rascol ; Bruno Dubois ; Alexandre Castro Caldas ; Stephen Senn ; Susanna Del Signore ; Andrew Lees | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 001264 (2006) |
Olivier Rascol ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "Olivier Rascol"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i \
-Sk "Olivier Rascol" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Corpus
|type= indexItem
|index= Author.i
|clé= Olivier Rascol
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
